Rhythm Biosciences jumps most in 7 months on New Zealand foray

Rhythm Biosciences

03/11/2022 24:47

** Shares of medical diagnostics tech co Rhythm Biosciences
 RHY.AX  rise as much as 14.9% to A$1.31, eyeing their best
session since April 4
    ** RHY says its cancer detection technology ColoSTAT® can
now be marketed and sold in New Zealand 
    ** Rhythm now registered as a manufacturer in New Zealand
    ** Pre-sales and commercial partnership discussions to make
the device available for use are progressing, says co
    ** Shares hit their highest levels since Sept. 14
    ** More than 337,000 shares change hands, compared with the
30-day average volume of 155,000 shares
    ** Stock down ~26.5% this year, as of last close
 (Reporting by Anan Ashraf in Bengaluru)
 ((Anan.Ashraf@thomsonreuters.com;))